Seeing Is Believing
Analyst Ed Arce works at HC WAINWRIGHT and is covering the the Healthcare sector with 188 price targets and ratings documented since 2017 spanning on 27 stocks.
Ed Arce's average stock forecast success ratio is 12.5% with an average time for price targets to be met of 6.15 days.
Most recent stock forecast was given on AKBA, Akebia Therapeutics, Inc at 30-May-2023.
Analyst best performing recommendations are on TERN.
The best stock recommendation documented was for TERN at 9/12/2022. The price target of $6 was fulfilled within 1 day with a profit of $0.3 (5.26%) receiving and performance score of 52.63.
Average potential price target upside
Currently, out of the existing stock ratings of Ed Arce - 3 which are a Buy (100%)
Current price target
Previous price target
Price targets met ratio
Average potential upside
Average time for PT to be met
8 days ago